Income Statement
BIOVENTUS INC.
BVS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
568.09 | 573.28 | 512.35 | 512.12 | 430.90 |
|
Cost of Revenue
|
179.93 | 185.05 | 184.15 | 181.04 | 128.19 |
|
Gross Profit
|
388.16 | 388.23 | 328.19 | 331.08 | 302.71 |
|
Operating Expenses
|
326.14 | 354.53 | 317.33 | 358.55 | 273.29 |
|
Research & Development
|
12.11 | 13.64 | 13.45 | 25.94 | 19.04 |
|
Selling, General & Administrative
|
314.03 | 340.89 | 303.88 | 332.61 | 254.25 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
62.02 | 33.69 | 10.87 | -27.47 | 29.41 |
|
Non-Operating Income
|
-28.27 | -37.15 | -39.39 | -12.85 | -4.44 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | 1.52 | 1.71 | 0.85 | 0.59 |
|
Other Non-Op Income / Expense
|
-1.45 | 1.65 | 1.29 | 12.94 | -3.33 |
|
Income Before Tax
|
25.71 | -49.13 | -121.11 | -263.90 | 7.62 |
|
Income Tax Expense
|
2.98 | -15.58 | 35.12 | -105.20 | -11.76 |
|
Non-Controlling Interest
|
- | - | - | -54.69 | -9.79 |
|
Net Income
|
22.73 | -33.54 | -156.23 | -158.70 | 19.38 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
67.75 | 41.35 | 19.71 | 39.34 | 64.29 |
|
Earnings Per Share (Basic)
|
0.34 | -0.52 | -2.49 | -2.59 | -0.15 |
|
Diluted EPS
|
0.33 | -0.52 | -2.49 | -2.59 | -0.15 |
|
Weighted Average Shares
|
66.62 | 64.55 | 62.65 | 61.39 | 45.47 |
|
Diluted Weighted Avg Shares
|
68.91 | 64.55 | 62.65 | 61.39 | 45.47 |
|
Comprehensive Income
|
23.41 | -36.91 | -155.33 | -158.99 | 18.12 |